Reach Out
  • Homepage
  • Meet the Team
  • Insights
Masavin
Pixivart
Masavin
  • Homepage
  • Meet the Team
  • Insights
© Copyright 2026

Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda

ArtemJuly 24, 2026
Cancer drug dealmaking is heating up around promising candidates with the potential to ... Read More

CEO of Otsuka North America: Are We Getting better access with AI?

ArtemJuly 19, 2026
Otsuka Pharmaceutical’s North American CEO —Tarek Rabah — has deep respect for all ... Read More

PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain

ArtemJuly 9, 2026
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among ... Read More

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France’s Largest Radiology Network

ArtemJuly 6, 2026
What You Should Know: – Lunit, a leading provider of AI-powered cancer diagnostics ... Read More

Unlocking Real-World Data to Advance Precision Medicine in 2025

ArtemJuly 5, 2026
The healthcare industry is a wellspring of data, from electronic health records to ... Read More

Bariatric Surgeries Decline as GLP-1s Use Rises, Impacting Hospital Margins

ArtemJuly 3, 2026
What You Should Know: – A new report from Strata Decision Technology reveals ... Read More

Posts pagination

1 2

PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain

July 9, 2026

The Future of Healthcare: AI-Powered Patient Experiences

June 28, 2026

How One Optum Exec Is Handling the Influx of Digital Mental Health Solutions

July 2, 2026
Custom Menu(Copy)
  • Homepage
  • Insights
  • Meet the Team
  • Let’s Talk
Custom Menu
  • Privacy Policy
  • Terms and Conditions
Logo
  • [email protected]
  • (866) 574-3047